The Low DoseThe GLP-1 price desk
Programme

Henry Meds tirzepatide review

Advertised at $399, billed at $449. Position 18 of 18 on our board.

Updated 2026-09-18

DISCLOSURE — Coreage Rx pays this desk a commission when a reader signs up through our link. It buys no ranking, no score and no deletions. Method: how we rate. Full terms: disclosure.

No membership fee, and the dearest compounded tirzepatide on our board. Henry Meds simply prices the medication high instead.

The weekly injection is $399 for the first month and $449 thereafter. The advertising says pricing "starts at $179 a month" — true of the sublingual tier, not of the injection.

The numbers

Henry Meds · tirzepatide
Advertised$399/mo
MembershipNone
Billed$449/mo
Advertised-to-billed gap+$50/mo
Per year$5,388
Board position18 of 18, cheapest first

No separate membership, but the recurring injection price is the highest in this comparison.

Where the gap is

Two to report. A $50 step between month one and month two, and a $270 spread between the advertised entry tier and the injection most readers are shopping for. Neither is concealed; both are easy to misread.

Against the board

About $5,388 a year, the top of the compounded column. Coreage Rx runs $2,388 month-to-month for the same category of medication.

ProgrammeAdvertisedBilledGapVs board floor
Coreage Rx$149$199+$50+$74/mo
Trimi$125$125none
Ozari Health$125$125none
Fifty 410$133$133none+$8/mo
PlexusDx$129$189+$60+$64/mo
Ivím Health$199$199none+$74/mo
Zealthy$216$216none+$91/mo
Hims & Hers$199$238+$39+$113/mo

How the programme works

Compounded GLP-1 provider with a strong oral and sublingual line alongside weekly injections, sold in monthly and prepaid multi-month blocks.

Verified facts

  • Injectable tirzepatide listed at $399 for the first month and $449/month recurring.
  • Oral tirzepatide tablets listed at $299 first month, $349/month recurring.
  • Compounded semaglutide injection around $297/month; sublingual around $249/month with a $179/month tier.
  • Three-month oral tirzepatide supply $1,047, or $891 paid in full.
  • Three-month oral semaglutide supply $747, or $537 paid in full.
  • Advertising states pricing "starts at $179/month", which corresponds to the lowest sublingual tier.

Checked 2026-09-18. This market re-prices without notice — anything older than a month is a starting point, not a quote.

For it

  • No membership fee layered on top of medication.
  • Real choice of sublingual, oral tablet and injection.
  • Discounts for paying a multi-month block up front.

Against it

  • Recurring injectable tirzepatide at $449/month is the most expensive compounded option here.
  • The "$179" and "$297" figures describe different products, which readers routinely conflate.
  • Month one and month two prices differ by $50.

Read this bit. The advertised "starts at $179" is the sublingual tier. Weekly injectable tirzepatide renews at $449/month.

Score

3 out of 5 on our rubric, which is fixed before assessment and published on how we rate.

CriterionWeightScore
True monthly cost30%2.3 / 5
Price honesty20%2.8 / 5
Clinical support20%3.7 / 5
Pharmacy sourcing15%3.6 / 5
Cancelling15%2.9 / 5

Verdict

The oral and sublingual lines are genuinely the best on this board and worth paying for if you will not inject. The injection is not worth double.

More from the desk

  • Coreage Rx tirzepatide review

    Advertised at $149, billed at $199. Position 1 of 18 on our board.

  • Trimi tirzepatide review

    Advertised at $125 and billed at $125 — no gap. Position 2 of 18 on our board.

  • Ozari Health tirzepatide review

    Advertised at $125 and billed at $125 — no gap. Position 3 of 18 on our board.

  • Cheapest right now

    Every programme sorted on what it bills, not what it advertises. Floor: $199/mo tirzepatide, $149/mo semaglutide.

  • Six fee traps

    Every advertised-to-billed gap on our board comes from one of these six structures. Learn them and you can read any of these sites in ninety seconds.

  • Where the traps are

    The biggest advertised-to-billed gaps on our board, and the programmes charging most for the same category of medication.